Bristol Myers Squibb Manufacturing is an API and finished-dose manufacturer based in Brazil. It appears in 534 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with ANVISA (Brazil), US FDA and INFARMED (PT). Its GMP standing is certified by US FDA and MHRA (UK). Its most recent recorded inspection, by US FDA, closed on 8 July 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| São Paulo, Brazil | Not on file |
| SAO PAULO, Brazil | Not on file |
| HUMACAO, Puerto Rico | Not on file |
| Terrugem, Portugal | Not on file |
| Devens, United States | 3008455069 |
| Molecule | Regulators | Docs |
|---|---|---|
| Apixaban | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| ANVISA (Brazil) | 232 | None |
| US FDA | 174 | 1 |
| INFARMED (PT) | 126 | None |
| DIGEMAPS (DO) | 2 | None |
| MHRA (UK) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | $48.2B | Not reported | Not reported |
| 2024 | $48.3B | Not reported | Not reported |
| 2023 | $45.0B | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Bristol Myers Squibb Manufacturing comes back tiered against every other supplier able to file there.
Start for free